Navigation Links
IBM and The Institute of Bioengineering and Nanotechnology Find Breakthrough for MRSA Treatment
Date:4/4/2011

esearch – Almaden. "With this discovery we've been able to leverage decades of materials development traditionally used for semiconductor technologies to create an entirely new delivery mechanism that could make drugs more specific and effective."

If commercially manufactured, these biodegradable nanostructures could be injected directly into the body or applied topically to the skin, treating skin infections through consumer products such as: deodorant, soap, hand sanitizer, table wipes and preservatives, as well as be used to help heal wounds, tuberculosis and lung infections.

"Using our novel nanostructures, we can offer a viable therapeutic solution for the treatment of MRSA and other infectious diseases. This exciting discovery effectively integrates our capabilities in biomedical sciences and materials research to address key issues in conventional drug delivery," said Dr. Yiyan Yang, Group Leader, Institute of Bioengineering and Nanotechnology, Singapore.

How it Works

The human body's immune system is designed to protect us from harmful substances, both inside and out. For a variety of reasons, many of today's conventional antibiotics are either rejected by the body or have a limited success rate in treating drug-resistant bacteria. The antimicrobial agents developed by IBM Research and the Institute of Bioengineering and Nanotechnology are specifically designed to target an infected area to allow for a systemic delivery of the drug.

Once these polymers come into contact with water in or on the body, they self assemble into a new polymer structure that is designed to target bacteria membranes based on electrostatic interaction and break through their cell membranes and walls. The physical nature of this action prevents bacteria from developing resistance to these nanoparticles.

The electric charge naturally found in cells is important because the new polymer structures are attracted only to the infecte
'/>"/>

SOURCE IBM
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Ontario Institute for Cancer Research Announces Investment in Microfluidics Technology for the Discovery of Anti-Cancer Drugs
2. Ontario Institute for Cancer Research Announces Enhancements to its Intellectual Property Development and Commercialization Program
3. Koch Institute for Integrative Cancer Research Dedicated Today
4. Sharpest microscope tip lands Canadas Nanotech Institute in Guinness Book of World Records
5. Weizmann Institute scientists used accelerated evolution to develop enzymes that provide protection against nerve gas
6. Polaris Group and The Ludwig Institute for Cancer Research Ltd Initiate Phase 2 Trial of Amino-Acid Degrading Enzyme, ADI-PEG 20, in Patients with Small Cell Lung Cancer
7. Larta Institute NIH Success Stories Featured in 2011 California Biomedical Industry Report
8. Tufts Launches Institute for Biopharmaceutical Partnerships
9. Salk Institute Celebrates Grand Opening of the Waitt Advanced Biophotonics Center
10. Will Rogers Institute Awards Top Doctor $50,000 for Outstanding Contributions to Lung Research
11. Weizmann Institute scientists used accelerated evolution to develop enzymes that provide protection against nerve gas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... (PRWEB) February 27, 2015 Immunovaccine ... and immunotherapy company, today announced that the U.S. ... for Fast Track designation and Phase I clinical ... conjunction with the mutual co-development agreement signed with ... Fast Track designation for the DPX-Survivac. , “We ...
(Date:2/27/2015)... February 27, 2015 FamilyFarms Group is ... Manager of State Line Farms, received the 2015 Tomorrow’s ... producer, under the age of 35, who has demonstrated ... an honor to win the Tomorrow's Top Producer Horizon ... won the Top Producer Award and learning from their ...
(Date:2/26/2015)... , Feb. 26, 2015 S&P Capital ... Factual Stock Report coverage on MabVax Therapeutics Holdings Inc ... is a clinical stage biotechnology company focused on the ... medical needs in the treatment of cancer. MabVax has ... on the protective immune responses generated by patients who ...
(Date:2/26/2015)... --  Synageva BioPharma Corp. (NASDAQ: ... for rare disorders, today reported 2014 full year ... objectives, and financial guidance.  Synageva,s management team will ... EST to review the financial results and provide ... call by telephone, please dial (877) 445-4603 for ...
Breaking Biology Technology:Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3Matt Sims Receives the 2015 Tomorrow’s Top Producer Horizon Award 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9
... ... ... Akaza Research is pleased to announce the release of OpenClinica 3.0, the newest version of ... trials. This latest production release marks a significant milestone for open source software in the ...
... TOKYO, Japan, October 14 Sosei ... company,today announces the assignment of the drug discovery ... UK biotechnology company and subsidiary of,PepTcell Limited. These ... were shown by Sosei to have pronounced anti-inflammatory ...
... at Arizona State University,s Biodesign Institute, N.J. Tao and ... electrical component on a phenomenally tiny scale. Their single-molecule ... Nature Chemistry . In the electronics ... in many shapes and sizes, they are used in ...
Cached Biology Technology:Impact of Open Source Software on Clinical Trials Grows With Release of OpenClinica 3.0 Electronic Data Capture Software 2Impact of Open Source Software on Clinical Trials Grows With Release of OpenClinica 3.0 Electronic Data Capture Software 3Sosei Announces Deal With UK Biotech Company 2Small ... smaller ... smallest? ASU researchers create molecular diode 2Small ... smaller ... smallest? ASU researchers create molecular diode 3
(Date:1/22/2015)... , Jan. 13, 2015 /PRNewswire/ - Today, FindBiometrics, the leading ... the launch of its new website design. "When ... its infancy", says Peter O,Neill , founder and CEO ... the industry needs involvement from the key players on a ...
(Date:1/22/2015)... , Jan. 20, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... market, reports on the recent success of the Wocket™ smart wallet at ... Wocket smart wallet was named as one of the "11 Hot Products ... Best Products Launched At CES So Far" by Newseveryday.com and "The top ...
(Date:1/22/2015)... , Jan. 22, 2015   EyeLock, Inc. , a ... has appointed Steve Gerber to the new role ... be responsible for leading development of mobile platforms and wearable ... of success and innovation in the semiconductor industry to his ...
Breaking Biology News(10 mins):Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2
... the availability of support online and the ease of which people ... the e-book market has been a rapidly expanding and profitable market. ... a car, drive to a location, hunt around a bookstore and ... great concept but it has one downside, at the store you ...
... pregnancy, women are normally advised to take high amounts ... reduce the risk of neural tube defects in newborns. ... fetal development, high vitamin doses during pregnancy may cause ... rats, an obesogenic phenotype is typically observed). A study ...
... brain that daydreams like humans do. Researchers created the ... the many connections those cells make with their neighbors and ... will help them understand why certain portions of the brain ... This, in turn, may one day help doctors better diagnose ...
Cached Biology News:Fat Loss Factor Review Gives Opinion of Popular Weight Loss Program 2Daydreaming simulated by computer model 2Daydreaming simulated by computer model 3
Phosphorylcholine hapten is conjugated to BSA protein by use of p-diazonium phenylphosphorylcholine....
Viral CMV UL146/vCXC1 Biotinylated Affinity Purified PAb...
Blue Standard is 3-cyano-7-hydroxycoumarin....
... Star strains are high-performance ... improved protein yield in ... (Figure 1). Because the ... mRNA more rapidly than ...
Biology Products: